Fig. 1
From: Repurposed agents in the Alzheimer’s disease drug development pipeline
Classification of repurposed agents by their FDA-approved indications (ClinicalTrials.gov as of February 27, 2020)
Fig. 1 | Alzheimer's Research & Therapy
